European Journal of Nuclear Medicine and Molecular Imaging

The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal published by Springer. It is the official journal of the European Association of Nuclear Medicine.[1] Since 1976, the EJNMMI has published material related to the field of nuclear medicine, including dosimetry, radiation biology, radiochemistry, radiopharmacology, molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression, and antisense methodologies. As of 2021, the EJNMMI has an impact factor of 10.057.[2]

European Journal of Nuclear Medicine and Molecular Imaging
DisciplineNuclear Medicine
LanguageEnglish
Edited byArturo Chiti
Publication details
History1976-present
Publisher
FrequencyMonthly
9.236 (2020)
Standard abbreviations
ISO 4Eur. J. Nucl. Med. Mol. Imaging
Indexing
CODENEJNMA6
ISSN1619-7070 (print)
1619-7089 (web)
LCCN2002252212
OCLC no.49348061
Links

Spin off

edit

In summer of 2011, Springer launched EJNMMI Research, a peer-reviewed open access journal, as a companion to the EJNMMI. It accommodates articles that could not be published in EJNMMI.

References

edit
  1. ^ "European Association of Nuclear Medicine - EJNMMI". Eanm.org. Archived from the original on 2012-10-24. Retrieved 2012-11-01.
  2. ^ "European Journal of Nuclear Medicine and Molecular Imaging". Springer. Springer. Retrieved June 26, 2023.
edit